V

Veracity Neuroscience, LLC. | Memphis, Tennessee

Research site

(Unclaimed)

Location

5050 Poplar Avenue Suite 511, Memphis, Tennessee, United States of America

Site insights

Top conditions

Top treatments

ABP-450

Buntanetap

CVN424

AMX0035

Zoledronic Acid

Prasinezumab

ABP-19000

Votoplam

Suvecaltamide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 15 total trials

A Study of Buntanetap in Participants With PD

This study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study. This study will...

Enrolling

Deep Brain Stimulation

Parkinson's Disease (PD)

Drug: buntanetap/posiphen

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease (PARAISO)

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with e...

Enrolling

Parkinson's Disease

Drug: Prasinezumab

Drug: Placebo

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease (INVEST-HD)

The purpose is to assess safety and tolerability of votoplam and to determine whether votoplam slows disease progression in patients with early sympt...

Enrolling

Huntington Disease

Drug: Placebo

Drug: Votoplam (blinded)

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Part...

Active, not recruiting

Parkinson Disease

Drug: Placebo

Drug: CVN424 75 mg